Profile: ProMetic Life Sciences Inc (PLI.TO)

PLI.TO on Toronto Stock Exchange

2.44CAD
5 Feb 2016
Change (% chg)

$-0.05 (-2.01%)
Prev Close
$2.49
Open
$2.51
Day's High
$2.53
Day's Low
$2.40
Volume
1,368,522
Avg. Vol
2,022,927
52-wk High
$3.62
52-wk Low
$1.39

Search Stocks
ProMetic Life Sciences Inc. (ProMetic) is a Canada-based biopharmaceutical company. The Company offers solutions in bioseparations, plasma-derived therapeutics and small-molecule drug development. ProMetic offers its technologies for large-scale purification of biologics, drug development, proteomics and the elimination of pathogens. The Company operates through two segments: Therapeutics and Protein Technology. Therapeutics segment is a small molecule drug discovery business. It has lead compounds, namely PBI-4050 indicated for the treatment of fibrosis in patients with chronic kidney diseases and certain cancers, and the side effects associated with chemotherapy. Protein Technology segment contains the financial information of the activities, including BioTherapeutics, Bioseparation and Prion Capture/Pathogen Removal.

Company Address

ProMetic Life Sciences Inc

440 Armand-Frappier Blvd Suite 3
LAVAL   QC   H7V 4B4
P: +1450.7810115
F: +1450.7814477

Company Web Links

Search Stocks